Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway (Q38708187)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway |
scientific article |
Statements
1 reference
Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway (English)
1 reference
Jinghui Sun
1 reference
Qing Luo
1 reference
Lingling Liu
1 reference
Xianjiong Yang
1 reference
Shunqin Zhu
1 reference
Guanbin Song
1 reference
7 April 2017
1 reference
1 reference
Identifiers
1 reference